Immunohistochemical markers of uterine myoma recurrence
- Authors: Tonoyan N.M.1, Kozachenko I.F.1, Asaturova A.V.1, Kometova V.V.1, Magnaeva A.S.1, Tevryukova N.S.1, Frankevich V.E.1, Adamyan L.V.1
-
Affiliations:
- Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia
- Issue: No 4 (2022)
- Pages: 123-131
- Section: Articles
- URL: https://journals.eco-vector.com/0300-9092/article/view/274469
- DOI: https://doi.org/10.18565/aig.2022.4.123-131
- ID: 274469
Cite item
Abstract
Full Text
About the authors
Narine M. Tonoyan
Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia
Email: tonnar.13@bk.ru
Obstetrician-Gynecologist at the Department of Operative Gynecology
Irena F. Kozachenko
Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of RussiaDr. Med. Sci., Senior Researcher at the Department of Operative Gynecology
Aleksandra V. Asaturova
Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia
Email: a_asaturova@oparina4.ru
Dr. Med. Sci., Head of the lst Pathology Department
Vlada V. Kometova
Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia
Email: v_kometova@oparina4.ru
PhD, Head of Oncopathology Department
Alina S. Magnaeva
Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia
Email: alinamagnaeva03@gmail.com
Junior Researcher at the lst Pathology Department
Nadezda S. Tevryukova
Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia
Email: n.s.tevrukova@yandex.ru
PhD, Senior Researcher at the lst Pathology Department
Vladimir E. Frankevich
Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia
Email: v_frankevich@oparina4.ru
PhD (Physics and Mathematics), Head of the Department of Systems Biology in Reproduction
Leyla V. Adamyan
Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia
Email: adamyanleila@gmail.com
Dr. Med. Sci., Professor, Academician of RAS, Head of the Department of Operative Gynecology
References
- Поротикова И.Е., Адамян Л.В., Гаврилова Т.Ю., Демура Т.А., Козаченко И.Ф., Доброхотова Ю.Э., Асатурова А.В. Особенности хирургического лечения больных миомой матки после ранее перенесенной неэффективной эмболизации маточных артерий и ФУЗ-МРТ абляции. Проблемы репродукции. 2016; 22(3): 45-52. [Porotikova I.E., Adamyan L.V., Gavrilova T.Yu., Demura T.A., Kozachenko I.Ph., Dobrokhotova Iu.E., Asaturova A.V. Surgical treatment of uterine myoma after ineffective UAE and MRgFUS ablation. Russian Journal of Human Reproduction. 2016; 22(3): 45-52. (in Russian)]. https://dx.doi.org/10.17116/repro201622345-52.
- Donnez J., Donnez O., Dolmans M.M. With the advent of selective progesterone receptor modulators, what is the place of myoma surgery in current practice? Fertil. Steril. 2014; 102(3): 640-8. https://dx.doi.org/10.1016/j.fertnstert.2014.06.041.
- Тоноян Н.М., Козаченко И.Ф., Франкевич В.Е., Чаговец В.В., Адамян Л.В. Рецидивы миомы матки. Современный взгляд на проблемы диагностики, лечения и прогнозирования. Акушерство и гинекология. 2019; 3: 32-8. [Tonoyan N.M., Kozachenko I.F., Frankevich V.E., Chagovets V.V., Adamyan L.V. Recurrences of uterine fibroids. The modern view on the problems of diagnosis, treatment, and prognosis. Obstetrics and Gynecology. 2019; 3: 32-8 (in Russian)]. https://dx.doi.org/10.18565/aig.2019.3.32-38.
- Малышкина А.И., Воскресенская Д.Л., Воронин Д.Н., Анциферова Ю.С., Сотникова Н.Ю., Малышкина Д.А. Иммунные механизмы регуляции роста миомы матки. Акушерство и гинекология. 2020; 2: 111-5. [Malyshkina A.I., Voskresenskaya D.L., Voronin D.N., Antsiferova Yu.S., Sotnikova N.Yu., Malyshkina D.A. Immune mechanisms of regulating the growth of uterine leiomyoma. Obstetrics and Gynecology. 2020; 2: 111-5. (in Russian)]. https://dx.doi.org/10.18565/aig.2020.2.111-115.
- Караваев Ю.Е., Аскольская С.И., Коган Е.А., Арсланян К.Н., Бурыкина П.Н. Прогностические критерии рецидива лейомиомы матки после реконструктивно-пластических операций. Акушерство и гинекология. 2013; 5: 54-7.
- Бурлев В.А. Локальный и системный ангиогенез у больных с миомой матки. Проблемы репродукции. 2007; 1: 26-33.
- Munro M.G., Critchley H.O., Fraser I.S.; FIGO Menstrual Disorders Working Group. The FIGO classification of causes of abnormal uterine bleeding in the reproductive years. Fertil. Steril. 2011; 95(7): 2204-8.e3. https://dx.doi.org/10.1016/j.fertnstert.2011.03.079.
- Баширов Э.В., Чуприненко Л.М., Крутова В.А. Пролиферативная активность и экспрессия рецепторов стероидных гормонов как предиктор рецидива лейомиомы после органосохраняющих вмешательств. Медицинский вестник Северного Кавказа. 2018; 13: 35-8. [Bashirov E.V., Chuprinenko L.M., Krutova V.A. Molecular biological predictors of myoma growth after organ-saving surgery. Medical News of North Caucasis. 2018; 13: 35-8. (in Russian)]. https://dx.doi.org/10.14300/mnnc.2018.13010.
- Мальков П.Г., Франк Г.А., ред. Основы обеспечения качества в гистологической лабораторной технике. Руководство. М.; 2011. 108 с.
- Сидорова И.С., Коган Е.А., Унанян А.Л., Киселев В.И., Агеев М.Б. Клиникоморфологические параллели различных вариантов роста миомы матки. Российский вестник акушера-гинеколога. 2019; 19(3): 29-36. [Sidorova I.S., Kogan E.A., Unanian A.L., Kiselev V.I., Ageev M.B. Clinical and morphological correlations for different types of uterine myoma growth. Russian Bulletin of Obstetrician-Gynecologist. 2019; 19(3): 29-36. (in Russian)]. https://dx.doi.org/10.17116/rosakush20191903129.
- Шрамко С.В., Бондарев О.И., Коваль Е.Ю., Лоскутова Е.Ю., Подтуркина Т.К., Шишея Е.Ю., Станков А.И., Елдинова О.Г. Биологические маркеры клеточного цикла Ki-67 и Bcl-2 при миоме, аденомиозе и лейомиосаркоме матки. Медицина в Кузбассе. 2019; 18(3): 20-4.
- Коган Е.А., Аскольская С.И., Попов Ю.В., Соломахина М.А., Файзуллина Н.М. Лейомиомы матки больших размеров: патогенетические механизмы роста. Клиническая практика. 2016; 7(1): 22-8.
- Liao X.H., Li J.Y., Dong X.M., Wang X., Xiang Y., Li H. et al. ERa inhibited myocardin-induced differentiation in uterine fibroids. Exp. Cell Res. 2017; 350(1): 73-82. https://dx.doi.org/10.10167j.yexcr.2016.11.007.
- Сидорова И.С., Рыжова О.В., Репин А.Б. Роль апоптоза и клеточной пролиферации в патогенезе гладкомышечных опухолей матки. Российский медико-биологический вестник имени академика И.П. Павлова. 2001; 3-4: 26-31.
- Nisolle M., Gillerot S., Casanas-Roux F., Squifflet J., Berliere M., Donnez J. Immunohistochemical study of the proliferation index, oestrogen receptors and progesterone receptors A and B. in leiomyomata and normal myometrium during the menstrual cycle and under gonadotrophin-releasing hormone agonist therapy. Hum. Reprod. 1999; 14(11): 2844-50. https://dx.doi.org/10.1093/humrep/14.11.2844.
- Коненков В.И., Королева Е.Г., Орлов Н.Б., Прокофьев В.Ф., Шевченко А.В., Новиков А.М. Сывороточные уровни факторов роста гемопоэза и ангиогенеза (IL-5, IL-7, IL-9, FGF-p, G-CSF, VEGF И. PDGF) у женщин с миомой матки. Медицинская иммунология. 2018; 20(5): 691-8. https://dx.doi.org/10.15789/1563-0625-2018-5-691-698.
- Maruo T., Ohara N., Wang J., Matduo H. Sex steroidal regulation of uterine leiomyoma growth and apoptosis. Hum. Reprod. Update. 2004; 10(3): 207-20. https://dx.doi.org/10.1093/humupd/dmh019.
- Тюрина А.А., Ящук А.Г., Имельбаева А.Г., Яковлева О.В. Роль прогестерона и тканевых факторов роста в патогенезе миомы матки. Практическая медицина. 2018; 16(6): 124-9. [Tyurina A.A., Yaschuk A.G., Imelbaeva A.G., Yakovleva O.V. The role of progesterone and tissue growth factors in pathogenesis of uterine myomas. Practical Medicine. 2018; 16(6): 124-9. (in Russian)]. https://dx.doi.org/10.32000/2072-1757-2018-16-6-124-129.
- Robinson-Rechavi M., Garcia H.E., Laudet V. The nuclear receptor superfamily. J. Cell Sci. 2003; 116(4): 585-6. https://dx.doi.org/10.1242/jcs.00247.
- Kirsch D.G., Kastan M.B. Tumor-suppressor p53: implications for tumor development and prognosis. J. Clin. Oncol. 1998; 16(9): 3158-68. https://dx.doi.org/10.1200/JCO.1998.16.9.3158.
- Kuhn E., Yemelyanova A., Wang T.L., Kurman R.J. Abstract 5536: TP53 and MED12 mutations in uterine smooth muscle tumors. Canser Res. 2012; 72(8, Suppl.): 5536. https://dx.doi.org/10.1158/1538-7445.AM2012-5536.
- Hakverdi S., Demirhan O., Tunc E., Inandiklioglu N., Uslu IN., Gungoren A. et al. Chromosome imbalances and alterations in the p53 gene in uterine myomas from the same family members: familial leiomyomatosis in Turkey. Asian Pac. J. Cancer Prev. 2013; 14(2): 651-8. https://dx.doi.org/10.7314/apjcp.2013.14.2.651.
- Atkins K.A., Arronte N., Darus C.J., Rice L.W. The use of p16 in enhancing the histologic classification of uterine smooth muscle tumors. Am. J. Surg. Pathol. 2008; 32(1): 98-102. https://dx.doi.org/10.1097/PAS.0b013e3181574d1e.
- Xie J., Ubango J., Ban Y., Chakravarti D., Kim J.J., Wei J.J. Comparative analysis of AKT and the related biomarkers in uterine leiomyomas with MED12, HMGA2, and FH mutations. Genes Chromosomes Cancer. 2018; 57(10): 485-94. https://dx.doi.org/10.1002/gcc.22643.